Based on our preliminary results, the development of novel small molecule drugs targeting Beclin 2 and Ubiquilin 1 is highly significant for the future.
← all excerpts
Deep learning identification of novel autophagic protein-protein interactions and experimental validation of Beclin 2-Ubiquilin 1 axis in triple-negative breast cancer.
1
—
—